Oncopeptides Chief Financial Officer Holger Lembrer takes office today PR Newswire STOCKHOLM, Jan. 18, 2023 STOCKHOLM , Jan. 18, 2023 /PRNewswire/ -- Oncopeptides AB (publ.) (NASDAQ Stockholm: ONCO), a biotech company focused on commercialization, research, and development of therapies for difficult-to-treat hematological diseases, today announces that Holger Lembrer, who recently was appointed Chief Financial Officer, CFO, takes the office on January 18 . "I am very pleased that Holger Lembrer...